...

TriCore Reference Laboratories and COPAN Announce Strategic Alliance with the Implementation of WASPLab™


05/12/2016

Murrieta, CA – May12th, 2016 – With the recent implementation of WASPLab™ and digital microbiology, COPAN Diagnostics, Inc. is pleased to announce a strategic alliance with TriCore Reference Laboratories.
 
TriCore Reference Laboratories, the largest clinical laboratory in New Mexico, added COPAN’s WASPLab™ to its state-of-the-art laboratory to further enhance their ability to provide valuable health information that changes lives. “The implementation of the WASPLabTM takes Microbiology to the next level, combining traditional methods with state of the art digital imaging,” stated Karissa Culbreath, PhD, TriCore’s Scientific Director, Infectious Disease. “Implementation of this system at TriCore Reference Laboratories allows us to leverage our expertise in microbiology and look to novel opportunities in digital imaging to reduce turnaround times and have a true patient impact.”
 
“TriCore evaluated alternate Microbiology automation options but felt that the WASPLab™ was the best fit due to its modular, scalable design. Additionally, TriCore has entered into a Center of Excellence agreement with COPAN which creates a mutually beneficial partnership allowing for input into future enhancements of this key investment,” stated Bill Remillard, TriCore’s Chief Technical Officer.
 
With the introduction of digital Microbiology and the advancement of point of care technologies, Microbiology is changing at a fast speed. WASPLab™ is a sophisticated system that automatically processes Microbiology specimens and uses sample barcodes to guide the specimen through the system, determining how to process it and when to image cultures. WASPLab™ connects WASP®DT Walk-Away Specimen Processor to the smart incubators using a conveyor track. In the incubators, the plates are imaged so they can be read digitally and when they are ready to be read. This moves the Microbiology laboratory from a batch process to a continuous workflow, reducing turnaround times for increased targeted intervention. TriCore Reference Laboratories considers this investment important for improving accessibility of diagnostic data to continue to increase the clinical significance of the laboratory for better population health management.
 
With the implementation of the Affordable Care Act (ACA) and the changes to healthcare, TriCore Reference Laboratories is pioneering change in the way laboratories think about patient care and is moving from a volume-based system to a value-based system, which is in line with COPAN’s vision for the future,” stated COPAN Diagnostics’ CEO, Norman Sharples. “We are really excited about TriCore selecting COPAN as its partner for full laboratory automation in Microbiology, as our companies share similar visions of reshaping the way healthcare is delivered, taking advantage of informatics and digital imaging,” concluded Sharples.
 
_______________
About COPAN Group
With a reputation for innovation, Copan is the leading manufacturer of collection and transport systems in the world.  Copan’s collaborative approach to preanalytics has resulted in Flocked Swabs, ESwab™, Universal Transport Medium and laboratory automation, WASP® and WASPLab.  Copan carries a range of microbial sampling products, inoculation loops, and pipettes.  For more information, visit www.copanusa.com
 
About TriCore Reference Laboratories
TriCore Reference Laboratories is an independent clinical reference laboratory providing a complete range of services to health care professionals across the Southwest as well as pathology consultation services to clinicians across the country. TriCore also provides investigational services including FDA-regulated clinical trials, IRB-approved studies, device and diagnostic instrument testing, serving global biotech firms as well as academic clients. For more information, visit www.tricore.org
 
 

TriCore in the News

Basics of Researching, Selecting, and Implementing New POCT Devices

Technology is advancing by leaps and bounds, and manufacturers release new point-of-care testing (POCT) devices almost daily. As news of a novel technology spreads, requests from hospitals, provider offices, urgent care sites, and other locations increase. Likewise, when the public becomes aware of the possibilities of faster testing, people start to expect that when they visit their provider or any other healthcare site, they’ll be able to get results and necessary treatment immediately. With emerging POCT devices, the days of hospital-based glucose and urine dipstick testing being the only tests available at patient bedside are in the past.

AACC,10/26/2021

ONE-ON-ONE: Karissa Culbreath — Medical Director, infectious disease chief, Tricore Reference Laboratories

There’s one sure way to get Karissa Culbreath to do something: Tell her she can’t.

“I am a highly competitive person and really all you have to do … is tell me that I can’t and then — ‘OK. Let’s go. Watch me,'” says Culbreath, medical director of infectious disease at TriCore Reference Laboratories.

Albuquerque Journal,02/25/2021

Database shows NM health care facilities receiving COVID-19 relief funds

A new federal database is giving a look at which New Mexico hospitals and health care providers received federal funding related to the coronavirus. The database published on the CDC’s website lists over 1,100 different New Mexico entities that received CARES Act aid funding under the federal Health and Human Services Provider Relief Fund.

KRQE TV 13,07/09/2020

One on One with Robin Divine

Robin Divine was on the job at TriCore Reference Laboratories for just a short time when the coronavirus threw the state’s largest clinical lab into “crisis mode.”

Albuquerque Journal,07/06/2020

Recent Tweets

Follow us on Twitter